
Orireb 20mg Tablet
Marketer
Orison Pharmaceuticals
Salt Composition
Rabeprazole (20mg)
Overview Orireb 20mg Tablet
Gastracid 20mg tablets lessen stomach acid production. This medication treats stomach and intestinal conditions stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and promoting healing. Take one Gastracid 20mg tablet an hour before meals, ideally in the morning. Dosage depends on your condition and response, so take it consistently as prescribed, even if symptoms improve rapidly. Smaller, more frequent meals and avoiding caffeine, spicy food, and fatty foods can aid symptom management. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Report persistent or bothersome side effects to your physician. Prolonged use (over a year), particularly at higher doses, may increase bone fracture risk. Discuss bone loss prevention, such as calcium and vitamin D supplements, with your doctor. Low magnesium (hypomagnesemia) has been observed after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor your magnesium levels. Gastracid 20mg tablets are unsuitable for individuals with severe liver disease, those on HIV medication, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding women should consult their doctor. Alcohol should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Orireb 20mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Orireb 20mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Orireb 20mg Tablet should be taken on an empty stomach.
Common Side effects of Orireb 20mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Orireb 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 20mg Orireb tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Orireb 20mg Tablet works:
Gastro-acid control is achieved with the 20mg Orireb tablet, a proton pump inhibitor (PPI) that lessens stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Orireb 20mg Tablet with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Orireb 20mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Orireb 20mg Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 20mg Orireb tablet might cause drowsiness, blurred vision, or dizziness. Driving is not recommended if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment may safely use Orireb 20mg tablets without requiring a dosage modification.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Orireb 20mg tablets are considered safe. No alteration of the Orireb 20mg tablet dosage is advised.
What if you forget to take Orireb 20mg Tablet :
Should you forget to take your Orireb 20mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orireb 20mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | PPIs (proton pump inhibitors) |
